| [1] |
Conaghan PG. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity[J].Rheumatol Int, 2012, 32(6): 1491-1502.
|
| [2] |
Sostres C, Gargallo CJ, Lanas A, et al. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage[J]. Arthritis Res Ther, 2013, 15(3): 1-8.
|
| [3] |
Badri W, Miladi K, Nazari QA, et al. Encapsulation of NSAIDs for inflammation management: Overview, progress, challenges and prospects[J]. Int J Pharm, 2016, 515(1-2): 757-773.
|
| [4] |
Nagasue T, Nakamura S, Kochi S, et al. Time trends of the impact of helicobacter pylori infection and nonsteroidal anti-inflammatory drugs on peptic ulcer bleeding in japanese patients[J]. Digestion, 2015, 91(1): 37-41.
|
| [5] |
Kocoglu H, Oguz B, Dogan H, et al. Do NSAIDs and ASA cause more upper gastrointestinal bleeding in elderly than adults[J]?. Gastroenterol Res Pract, 2016: 8419304.
|
| [6] |
汪晓强，陈辉，熊源长.中国五省居民对非甾体抗炎药的认知及误用情况调查[J].中国疼痛医学杂志, 2015, 21(11): 840-844.
|
| [7] |
Lichtenberger LM, Zhou Y, Jayaraman V, et al. Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine[J]. Biochim Biophys Acta, 2012, 1821(7): 994-1002.
|
| [8] |
Suthar SK, Sharma M. Recent developments in chimeric NSAIDs as safer anti-inflammatory agents[J]. Med Res Rev, 2015, 35(2): 341-407.
|
| [9] |
Bjarnason I. Gastrointestinal safety of NSAIDs and over-the-counter analgesics[J]. Int J Clin Pract Suppl, 2013, 67(178): 37-42.
|
| [10] |
Nagano Y, Matsui H, Shimokawa O, et al. Rebamipide attenuates nonsteroidal anti-inflammatory drugs (NSAID) induced lipid peroxidation by the manganese superoxide dismutase (MnSOD) overexpression in gastrointestinal epithelial cells[J].J Physiol Pharmacol, 2012, 63(2): 137-142.
|
| [11] |
汤光，李大魁.现代临床药物学[M].北京：化学工业出版社，2008：159-160.
|
| [12] |
张彭，王孟春.非甾体抗炎药致胃肠道黏膜损伤的研究进展[J].实用药物与临床, 2008, 11(6): 378-380.
|
| [13] |
Suthar SK, Sharma M. Recent developments in chimeric NSAIDs as safer anti-inflammatory agents[J].Med Res Rev, 2015, 35(2): 341-407.
|
| [14] |
Lanas A, Ferrandez A. NSAID-induced gastrointestinal damage: Current clinical management and recommendations for prevention[J].Chin J Dig Dis, 2006, 7(3):127-133.
|
| [15] |
Yap PR, Goh KL. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) induced dyspepsia[J]. Curr Pharm Des, 2015, 21(35): 5073-5081.
|
| [16] |
陈晓露.非甾体抗炎药致上消化道黏膜损伤并出血的特点分析[J].现代消化及介入诊疗, 2016, 21(4): 617-619.
|
| [17] |
Iwakiri R, Fujimoto K. Roles of NSAIDs and aspirin in bleeding peptic ulcers: NSAIDs, aspirin and peptic ulcers[J]. Clin J Gastroenterol, 2008, 1(2): 33-39.
|
| [18] |
Al-Shidhani A, Al-Rawahi N, Al-Rawahi A, et al. Non-steroidal Anti-inflammatory Drugs (NSAIDs) use in Primary Health Care Centers in A'Seeb, Muscat: a clinical audit[J]. Oman Med J, 2015, 30(5): 366-371.
|
| [19] |
Shrestha UK, Jha RK, Xia B. Evolution of novel non-steroidal anti-inflammatory drugs with reduced gastrointestinal adverse effects[J]. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 2009, 8(3): 270-278.
|
| [20] |
宗晔，赵海英.NSAIDs相关性消化性溃疡出血与非NSAIDs消化性溃疡出血的临床对照研究[J].临床和实验医学杂志, 2012, 11(11): 828-829.
|
| [21] |
Miyake K, Kusunoki M, Ueki N, et al. Implication of antithrombotic agents on potential bleeding from endoscopically determined pepticulcers, incidentally detected as surrogate markers for nsaids-associated ulcers complication[J]. Digestive endoscopy, 2013, 25(1): 25-31.
|
| [22] |
Sostres C, Carrera-Lasfuentes P, Benito R, et al. peptic ulcer bleeding risk. the role of helicobacter pylori infection in NSAID/Low-dose aspirin users[J]. Am J Gastroenterol, 2015, 110(5): 684-689.
|
| [23] |
de Abajo FJ, Gil MJ, Bryant V, et al. Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database[J]. Eur J Clin Pharmacol, 2013, 69(3): 691-701.
|
| [24] |
Dib RA, Chinzon D, Fontes LH, et al. Ulcer and bleeding complications and their relationship with dyspeptic symptoms in NSAIDs users: a transversal multicenter study[J]. Scand J Gastroenterol, 2014, 49(7): 785-789.
|
| [25] |
Kim SB, Lee SH, Kim KO, et al. Risk factors associated with rebleeding in patients with high risk peptic ulcer bleeding: focusing on the role of second look endoscopy[J].Dig Dis Sci, 2016, 61(2): 517-522.
|
| [26] |
抗血小板药物消化道损伤的预防和治疗中国专家共识组.抗血小板药物消化道损伤的预防和治疗中国专家共识[J].中华内科杂志, 2013, 52(3): 264-270.
|
| [27] |
张幸国，胡丽娜.临床药物治疗性[M].北京：人民卫生出版社，2015：18-19.
|
| [28] |
Rainsford KD, Bjarnason I. NSAIDs:take with food or after fasting[J]? J Pharm Pharmacol, 2012, 64(4): 465-469.
|
| [29] |
张文燕，袁耀宗.非甾体抗炎药的胃肠损害及其预防[J].药物不良反应杂志, 2008, 10(3): 190-195.
|
| [30] |
Lee YY, Noridah N, Syed Hassan SA, et al. Absence of Helicobacter pylori is not protective against peptic ulcer bleeding in elderly on offending agents: lessons from an exceptionally low prevalence population[J]. Peer J, 2014, 2: e257.
|
| [31] |
Takeuchi K, Kato S, Amagase K. Prostaglandin EP receptors involved in modulating gastrointestinal mucosal integrity [J]. J Pharmacol Sci, 2010, 114(3): 248-261.
|
| [32] |
Lee OY, Kang DH, Lee DH, et al. A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment[J]. Arch Pharm Res, 2014, 37(10): 1308-1316.
|
| [33] |
Cheetham TC, Levy G, Niu F, et al. Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin[J]. Ann Pharmacother, 2009, 43(11): 1765-1773.
|
| [34] |
Nagata N, Niikura R, Sekine K, et al. Risk of peptic ulcer bleeding associated with Helicobacterpylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: A case-control study[J]. J Gastroenterol Hepatol, 2015, 30(2): 292-298.
|
| [35] |
Dovjak P. Duodenal ulcers, gastric ulcers and Helicobacter pylori[J]. Z Gerontol Geriatr, 2017, 50(2): 159-169.
|
| [36] |
刘艳红，周小平，刘荣华.非甾体抗炎药研究进展[J].江西中医药, 2013, 44(11): 78-80.
|
| [37] |
Chang SS. Re: preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model[J]. J Urol, 2015, 193(5): 1727.
|
| [38] |
Qandil AM. Prodrugs of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), more than meets the eye: a critical review[J]. Int J Mol Sci, 2012, 13(12): 17244-17274.
|
| [39] |
Magliocca S, Sodano F, Nieddu M. New galactosylated NSAIDs prodrugs in a green context:synthesis and stability[J].Int J Pharm Res, 2017, 8(4): 1575-1581.
|